Bioterrorism Web Sites for Pharmacists

2003 ◽  
Vol 37 (1) ◽  
pp. 132-135 ◽  
Author(s):  
Caron P Misita ◽  
Andrea B Boosinger ◽  
Michael G Kendrach
Keyword(s):  
Web Sites ◽  
Pharmacy Practice ◽  
Health Department ◽  
Related Information ◽  
Johns Hopkins University ◽  
Pharmacy Profession ◽  
Us Government ◽  
Control And Prevention ◽  
American Pharmaceutical Association ◽  
American Society

OBJECTIVE To identify Internet Web sites for ease of accessibility to bioterrorism-related information, comprehensive provision of bioterrorism-related information, and provision of bioterrorism information that specifically pertains to the pharmacy profession. DATA SOURCES Web sites of national pharmacy organizations, US government agencies, and medical organizations, as well as Web sites related to bioterrorism. DATA SYNTHESIS Pharmacists need access to relevant bioterrorism information in a timely manner. An evaluation of Web sites was performed to identify those that include a discussion of the potential infectious microorganisms and prevention and treatment methods, as well as unique features for pharmacy practice. RESULTS The American Society of Health-System Pharmacists and American Pharmaceutical Association Web sites provide pharmacy-specific recommendations. The Centers for Disease Control and Prevention provides biological agent information and health department contact numbers. Additional agent-specific data are provided by the American Medical Association, The Johns Hopkins University, and the Food and Drug Administration (FDA) Web sites. Information addressing food safety is provided by the FDA. CONCLUSIONS Pharmacy-specific bioterrorism information is available only at selected national pharmacy organization Internet Web sites. However, other Web sites provide comprehensive bioterrorism information useful for pharmacists.

A Practical Approach for Training Pharmacists and Pharmacy Students to Prevent Disease by Immunizations

2009 ◽  
Vol 22 (5) ◽  
pp. 513-517 ◽  
Author(s):  
Mary F. Powers ◽  
Folasade O. Akala ◽  
Diane M. Cappelletty ◽  
Jessica J. Shimman ◽  
Megan A. Kaun ◽  
...  
Keyword(s):  
Life Support ◽  
Pharmacy Practice ◽  
Health Department ◽  
Pharmacy Students ◽  
Significant Advance ◽  
Local Health ◽  
Certification Programs ◽  
Control And Prevention ◽  
Important Means ◽  
Needle Sticks

Immunization provides an important means for preventing communicable diseases. In recent years, administering immunizations has become part of contemporary pharmacy practice. Some view pharmacist-administered immunizations as a significant advance in the practice of pharmacy for providing care to patients. In Ohio, pharmacists may administer immunizations and pharmacists are not required to notify the patient’s physician or the local health department. There is a need for pharmacy students to obtain immunization certification so they are prepared for practice in the pharmacies of today. Including a training program for pharmacy students as immunizers is consistent with the American Association of Colleges of Pharmacy Center for the Advancement of Pharmaceutical Education Educational Outcomes 2004. The objective of this article is to describe an immunization certification program for pharmacists and pharmacy students based on the requirements of Ohio Law and guidelines of the Centers for Disease Control and Prevention. Program structures for certification programs for pharmacists and pharmacy students are described and include an immunology review, a review of specific immunization medications, a review of aseptic technique, administration techniques, proper disposal procedures, accidental needle sticks, and basic life support training. Teaching methodologies are identified and methods of assessment for mastery of the course elements are listed.

The hydroid research of American naturalist Samuel F. Clarke, 1851–1928

1997 ◽  
Vol 24 (1) ◽  
pp. 19-36 ◽  
Author(s):  
DALE R. CALDER ◽  
LESTER D. STEPHENS
Keyword(s):  
Developmental Biology ◽  
Taxonomic Status ◽  
Doctoral Dissertation ◽  
Nominal Species ◽  
Marine Biological Laboratory ◽  
Spotted Salamander ◽  
Johns Hopkins University ◽  
American Naturalist ◽  
American Schools ◽  
American Society

Samuel Fessenden Clarke was the leading specialist on hydroids (phylum Cnidaria) in North America over the last quarter of the nineteenth century. During that period he published taxonomic papers on hydroids from both the Atlantic and Pacific coasts of the continent, from the Gulf of Mexico, and from the eastern Pacific off Central and South America. He also authored a section on hydrozoan biology for “The Riverside Natural History” series. Most of his papers on hydroids were published while he was in his twenties. Clarke described as new 61 nominal species, three nominal genera, and one nominal family, as well as two “varieties” of hydroids. A list of these, and their current taxonomic status, appears in the present work. Clarke consistently provided sound descriptions and locality data for all supposed new species, and drew accurate illustrations of most of them. His research on Hydrozoa, beyond alphataxonomy, was directed towards faunal distributions and the use of hydroid assemblages as biogeographic indicators. In addition to investigations on hydroids, Clarke carried out research on the developmental biology of amphibians and reptiles. His doctoral dissertation at Johns Hopkins University was based on the embryology of the “Spotted Salamander” (=Yellow-spotted Salamander), and he published a major paper on the habits and embryology of the American Alligator. Most of Clarke's career was devoted to academic duties at Williams College, Massachusetts, where he was recognized as a dedicated and inspiring teacher. He served the American Society of Naturalists in various capacities, including a term as its president, was an influential trustee of the Marine Biological Laboratory, Woods Hole, and promoted the study of science in American schools.

scholarly journals Development of a Remote Public Health Advanced Pharmacy Practice Experience in Response to COVID-19

2021 ◽  
pp. 089719002110048
Author(s):  
Tyler Marie Kiles ◽  
Tracy Hagemann ◽  
Brianna Felts ◽  
Catherine Crill
Keyword(s):  
Public Health ◽  
Disaster Response ◽  
Pharmacy Practice ◽  
Health Department ◽  
Health Science ◽  
Science Center ◽  
Health Crisis ◽  
University Of Tennessee ◽  
Practice Experience ◽  
Phone Calls

Objectives: In order to meet the needs of the COVID-19 public health crisis and to actively engage students in patient care opportunities, the University of Tennessee Health Science Center College of Pharmacy in partnership with the Tennessee Health Department, developed a remote Public Health Advanced Pharmacy Practice Experience (APPE) Elective. The objectives of this paper are to describe the development of and students’ experiences and learning outcomes during the elective. Faculty preceptor and experiential administrator’s perspectives are also described. Methods: This month-long APPE was developed in mid-March and delivered in April and May of 2020. The students volunteered in-person with the State of Tennessee COVID-19 Hotline call centers and conducted topic discussions and assignments virtually with a remote preceptor. Results: A total of 16 students completed this rotation experience. Student ratings of the experience were positive, and their knowledge improved in all topic areas. Students collectively completed approximately 700 hours manning the COVID-19 hotline and logged over 1,000 phone calls. Conclusions: In a time of unprecedented disruption to experiential learning, the development of this unique public health APPE directly benefited the college, the students, and the citizens of our state. The APPE described in this paper could be replicated in additional waves of the pandemic or adapted for similar disaster response.

scholarly journals Five regions, five retinopathy screening programmes: a systematic review of how Portugal addresses the challenge

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Andreia Marisa Penso Pereira ◽  
Raul Manuel da Silva Laureano ◽  
Fernando Buarque de Lima Neto
Keyword(s):  
Diabetic Retinopathy ◽  
Web Sites ◽  
National Health System ◽  
Health Department ◽  
Population Based ◽  
Care Providers ◽  
Levels Of Care ◽  
Diabetic Retinopathy Screening ◽  
Relevant Role ◽  
Retinopathy Screening

Abstract Background The implementation of a population-based screening programme for diabetic retinopathy involves several challenges, often leading to postponements and setbacks at high human and material costs. Thus, it is of the utmost importance to promote the sharing of experiences, successes, and difficulties. However, factors such as the existence of regional programmes, specificities of each country’s health systems, organisational and even linguistic barriers, make it difficult to create a solid framework that can be used as a basis for future projects. Methods Web of Science and PubMed platforms were searched using appropriate key words. The review process resulted in 423 articles adherent to the search criteria, 28 of which were accepted and analysed. Web sites of all Portuguese governmental and non-governmental organisations, with a relevant role on the research topic, were inspected and 75 official documents were retrieved and analysed. Results Since 2001, five regional screening programmes were gradually implemented under the guidelines of Portuguese General Health Department. However, complete population coverage was still not achieved. Among the main difficulties reported are the complex articulation between different levels of care providers, the low number of orthoptic technician in the national health system, the high burden that images grading, and treatment of positive cases represents for hospitals ophthalmology services, and low adherence rates. Yet, the comparison between strategies adopted in the different regions allowed the identification of potential solutions: hire orthoptic technician for primary health care units, eliminating the dependence of hospital professionals; use artificial intelligence algorithms for automatic retinographies grading, avoiding ophthalmologists overload; adoption of proximity strategies, as the use of portable retinographers, to promote adherence to screening. Conclusion Access to diabetic retinopathy screening remains remarkably variable in Portugal and needs urgent attention. However, several characteristics of effective screening programmes were found in Portuguese screening programmes, what seems to point toward promising outcomes, especially if each other highlights are considered. The findings of this research could be very useful for the other countries with similar socio-political characteristics. Trial registration PROSPERO registration ID CRD42020200115.

Anticancer Therapy in COViD-19 Patients: A Descriptive Literature Review

2021 ◽  
Vol 36 (8) ◽  
pp. 365-373
Author(s):  
Nishita Tripathi ◽  
Daniya Sheikh ◽  
Demetra Antimisiaris
Keyword(s):  
Literature Review ◽  
Older People ◽  
Cancer Patients ◽  
Clinical Outcomes ◽  
Anticancer Therapy ◽  
Included Study ◽  
Adverse Outcomes ◽  
Control And Prevention ◽  
Anticancer Treatment ◽  
American Society

OBJECTIVE: To provide a descriptive literature review about the effects of anticancer treatment on clinical outcomes because of active COVID-19 infection in older people. DATA SOURCES: A literature search was conducted in Google Scholar, PubMed, American Society of Clinical Oncology, European Society for Medical Oncology, and the Center for Disease Control and Prevention. Articles published in English between December 1, 2019, to September 1, 2020, were included. STUDY SELECTION: Nine studies assessing the effectiveness of various modalities for cancer treatments in patients infected with COVID-19 infection were reviewed. The studies reviewed the severity of COVID-19 infection outcomes in patients who underwent any anticancer treatment. Studies exclusively focused on older people could not be found, but all studies included older people. DATA SYNTHESiS AND RESULTS: Early pandemic studies suggested avoiding anticancer treatment during a COVID-19 infection because of poor clinical outcomes and increased mortality. However, the totality of studies reviewed found no association between the continuation of anticancer treatment and adverse COVID-19 outcomes in cancer patients. Adverse COVID-19 infection outcomes and high mortality rates were associated with older cancer patients independent of anticancer therapy. CONCLUSION: Treatment of cancer could be challenging because of the COVID-19 pandemic. Interruption or delaying the anticancer therapy could increase the burden of overall mortality. This literature review indicated that adverse outcomes because of COVID-19 are associated with advanced age independent of anticancer therapy. Further exploration of the correlation between cancer, anticancer treatments, and COVID-19 infection outcomes is needed.

Sign in / Sign up

Export Citation Format

Share Document